These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23709434)

  • 1. Stepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathy.
    Shin DH; Lee MJ; Oh HJ; Koo HM; Doh FM; Kim HR; Han JH; Park JT; Han SH; Choi KH; Yoo TH; Kang SW
    Yonsei Med J; 2013 Jul; 54(4):973-82. PubMed ID: 23709434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy.
    Kim Y; Yoon HE; Chung BH; Choi BS; Park CW; Yang CW; Kim YS; Hong YA; Kim SY; Chang YK; Hwang HS
    Korean J Intern Med; 2019 Sep; 34(5):1091-1099. PubMed ID: 31408925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
    Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
    Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
    Fervenza FC; Appel GB; Barbour SJ; Rovin BH; Lafayette RA; Aslam N; Jefferson JA; Gipson PE; Rizk DV; Sedor JR; Simon JF; McCarthy ET; Brenchley P; Sethi S; Avila-Casado C; Beanlands H; Lieske JC; Philibert D; Li T; Thomas LF; Green DF; Juncos LA; Beara-Lasic L; Blumenthal SS; Sussman AN; Erickson SB; Hladunewich M; Canetta PA; Hebert LA; Leung N; Radhakrishnan J; Reich HN; Parikh SV; Gipson DS; Lee DK; da Costa BR; Jüni P; Cattran DC;
    N Engl J Med; 2019 Jul; 381(1):36-46. PubMed ID: 31269364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
    Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
    J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
    Howman A; Chapman TL; Langdon MM; Ferguson C; Adu D; Feehally J; Gaskin GJ; Jayne DR; O'Donoghue D; Boulton-Jones M; Mathieson PW
    Lancet; 2013 Mar; 381(9868):744-51. PubMed ID: 23312808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
    Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
    Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
    Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
    Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
    Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of membranous nephropathy.
    Ponticelli C; Passerini P
    Nephrol Dial Transplant; 2001; 16 Suppl 5():8-10. PubMed ID: 11509678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
    Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
    Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yokoyama H; Yamamoto R; Imai E; Maruyama S; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Fukami K; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Furuichi K; Fujimoto K; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2020 Oct; 24(10):893-909. PubMed ID: 32562107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy.
    Li MX; Yu YW; Zhang ZY; Zhao HD; Xiao FL
    Genet Mol Res; 2015 Mar; 14(1):2665-73. PubMed ID: 25867415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.